Sign up for free insights newsletter
EB

EBOS Group Limited

EBOSYUnited States

Need professional-grade analysis? Visit stockanalysis.com

$37.69
+0.00%
End of day
Market Cap

$3.86B

P/E Ratio

25.64

Employees

5,800

Dividend Yield

2.82%

Price Chart

Risk-Adjusted Performance

Ratio1W1M3M6M1Y5YScore
Sortino6.632.96-0.97-0.621.08
Calmar27.166.45-1.17-0.524.74
Sharpe3.191.44-0.79-0.500.36
Omega2.492.490.590.671.30
Martin54.3323.70-1.42-0.9112.11
Ulcer2.651.4413.559.397.91

EBOS Group Limited (EBOSY) Price Performance

EBOS Group Limited (EBOSY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at $37.69.

Over the past year, EBOSY has traded between a low of $35.03 and a high of $41.94. The stock has lost 8.5% over this period. It is currently 10.1% below its 52-week high.

EBOS Group Limited has a market capitalization of $3.86B, with a price-to-earnings ratio of 25.64 and a dividend yield of 2.82%.

About EBOS Group Limited

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.

Company Info

Exchange
United States
Currency
USD

Financial Metrics

Revenue (TTM)
$13.04B
EBITDA
$497.71M
Profit Margin
1.76%
EPS (TTM)
1.47
Book Value
9.38

Technical Indicators

52 Week High
$46.16
52 Week Low
$35.03
50 Day MA
$35.56
200 Day MA
$38.64
Beta
0.18

Valuation

Trailing P/E
25.64
Forward P/E
23.15
Price/Sales
0.30
Price/Book
2.06
Enterprise Value
$3.75B